FULCRUM THERAPEUTICS INC
FULCNASDAQ🏆 #3107 by market capEarnings Oct 29US Equity
$3.70▲ $0.01 (+0.14%)
Live1h▼ 0.1%
24h▲ 0.1%
7d▼ 2.0%
14d▲ 1.8%
30d▲ 4.1%
1y▼ 43.3%
🏦Market Cap
$246M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
3.5x
Fair
Otter Score
52
Weak
📊
Analyst Ratings
Price
$3.70
Total
17
Raised
1
Lowered
7
Avg PT
$3.60
H / L
$4 / $3
| Institution | Action | Rating | Date |
|---|---|---|---|
JP Morgan | Downgraded | Overweight → Underweight | 2026-06-03 |
Truist Securities | Downgraded | Buy → Hold | 2026-06-02 |
Piper Sandler | Downgraded | Overweight → Underweight | 2026-06-02 |
Leerink Partners | Downgraded | Outperform → Market Perform | 2026-06-02 |
HC Wainwright & Co. | Downgraded | Buy → Neutral | 2026-06-02 |
Stifel | Downgraded | Buy → Hold | 2026-06-02 |
B of A Securities | Reiterated | Underperform | 2025-12-09 |
RBC Capital | Reiterated | Sector Perform | 2025-12-08 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-12-08 |
Oppenheimer | Reiterated | Outperform | 2024-05-14 |
Goldman Sachs | Upgraded | Neutral → Buy | 2024-05-14 |
Credit Suisse | Downgraded | Outperform → Neutral | 2023-03-10 |
Morgan Stanley | Reiterated | Equal Weight | 2023-03-10 |
SVB Leerink | Reiterated | Outperform | 2021-08-13 |
BTIG | Reiterated | Buy | 2020-06-17 |
H.C. Wainwright | Reiterated | Buy | 2020-03-06 |
Bank of America | Reiterated | Buy | 2019-08-12 |
One row per institution, most recent rating